|
Oct 1
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jul 21
|
Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)
|
|
Jun 21
|
Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
|
|
May 28
|
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
|
|
May 28
|
ABEO: BLA Resubmission in 2H24
|
|
May 16
|
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
|
|
May 16
|
Q1 2024 Abeona Therapeutics Inc Earnings Call
|
|
May 15
|
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
|
|
May 3
|
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
|
|
Apr 25
|
ABEO: Receives CRL Based on Need for More CMC Information…
|
|
Apr 23
|
FDA rejects Abeona cell therapy, asks for more manufacturing data
|
|
Apr 22
|
Abeona Therapeutics Provides Regulatory Update on Pz-cel
|
|
Mar 26
|
Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
|
|
Mar 19
|
Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results
|
|
Mar 18
|
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
|
|
Mar 10
|
Several Insiders Invested In Abeona Therapeutics Flagging Positive News
|
|
Jan 16
|
Abeona Therapeutics Inc. (NASDAQ:ABEO): When Will It Breakeven?
|
|
Dec 23
|
Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%
|
|
Nov 29
|
ABEO: BLA for Pz-Cel (EB-101) Accepted with Priority Review; PDUFA Date of May 25, 2024…
|
|
Nov 27
|
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
|